In ACS with planned invasive evaluation, prasugrel vs ticagrelor reduced a composite of death, MI, or stroke at 1 y

Ann Intern Med. 2020 Jan 21;172(2):JC5. doi: 10.7326/ACPJ202001210-005.
No abstract available

Publication types

  • Comment

MeSH terms

  • Acute Coronary Syndrome*
  • Humans
  • Platelet Aggregation Inhibitors
  • Prasugrel Hydrochloride
  • Stroke*
  • Ticagrelor

Substances

  • Platelet Aggregation Inhibitors
  • Prasugrel Hydrochloride
  • Ticagrelor